Literature DB >> 17123656

Sequence polymorphisms in the long terminal repeat of bovine leukemia virus: evidence for selection pressures in regulatory sequences.

Xiangrong Zhao1, Carlos Jimenez, Hiroshi Sentsui, Gertrude C Buehring.   

Abstract

Bovine leukemia virus (BLV) is an oncogenic virus widespread in cattle. It belongs to the genus Deltaretrovirus of the family Retroviridae along with human and simian T-lymphotropic viruses. The BLV transcriptional promoter is located in the proviral 5' long terminal repeat (LTR), composed of U3, R, and U5 regions. BLV LTR contains multiple cis-acting elements important for promoter activity, a short coding sequence (encoding the NH(2) terminus of the G4 regulatory protein), and non-regulatory/non-coding regions. Variation in coding sequences of BLV structural proteins has been studied extensively, but little work has been done on sequence variability of non-coding regions, mostly located in LTR. Here, we report the first study on the natural diversity of the BLV LTR, using viral isolates from 52 cattle in several different areas worldwide. Nucleotide variations from the consensus sequence were observed in most isolates and clustered phylogenetically, corresponding to the geographic distribution of donor cattle. Overall, regulatory regions were significantly more conserved than non-regulatory regions in the BLV LTR, as well as in LTR sub-regions (U3, R, and U5). Evidence of selection pressures in BLV LTR suggests that selection occurs not only in coding sequences, but may also involve regulatory sequences.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17123656     DOI: 10.1016/j.virusres.2006.10.010

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  7 in total

1.  Similar patterns of infection with bovine foamy virus in experimentally inoculated calves and sheep.

Authors:  Magdalena Materniak; Torsten Hechler; Martin Löchelt; Jacek Kuzmak
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

2.  Bovine leukemia virus DNA in human breast tissue.

Authors:  Gertrude Case Buehring; Hua Min Shen; Hanne M Jensen; K Yeon Choi; Dejun Sun; Gerard Nuovo
Journal:  Emerg Infect Dis       Date:  2014-05       Impact factor: 6.883

Review 3.  Epidemiology and genetic diversity of bovine leukemia virus.

Authors:  Meripet Polat; Shin-Nosuke Takeshima; Yoko Aida
Journal:  Virol J       Date:  2017-11-02       Impact factor: 4.099

4.  In vitro Susceptibility of Human Cell Lines Infection by Bovine Leukemia Virus.

Authors:  Nury N Olaya-Galán; Skyler Blume; Kan Tong; HuaMin Shen; Maria F Gutierrez; Gertrude C Buehring
Journal:  Front Microbiol       Date:  2022-03-14       Impact factor: 5.640

5.  No evidence of bovine leukemia virus proviral DNA and antibodies in human specimens from Japan.

Authors:  Meripet Polat Yamanaka; Susumu Saito; Yukiko Hara; Ryosuke Matsuura; Shin-Nosuke Takeshima; Kazuyoshi Hosomichi; Yasunobu Matsumoto; Rika A Furuta; Masami Takei; Yoko Aida
Journal:  Retrovirology       Date:  2022-05-18       Impact factor: 4.602

6.  Bovine leukemia virus long terminal repeat variability: identification of single nucleotide polymorphisms in regulatory sequences.

Authors:  Aneta Pluta; Marzena Rola-Łuszczak; Renée N Douville; Jacek Kuźmak
Journal:  Virol J       Date:  2018-10-25       Impact factor: 4.099

Review 7.  Regulation of Expression and Latency in BLV and HTLV.

Authors:  Aneta Pluta; Juan P Jaworski; Renée N Douville
Journal:  Viruses       Date:  2020-09-25       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.